Monday, May 20, 2013

How to Get Your Mojo Back: Introducing the SexyBack Summit!

lost-your-libido-sara-300x250Are you suffering from low libido? Has your sex drive gradually drifted away? Are you looking for ways to connect more deeply with your partner, and cultivate a more rewarding and satisfying sex life?

If you answered yes to any of these questions, you should definitely check out Sean Croxton’s upcoming SexyBack Summit. He’s assembled a group of experts in all aspects of sexual health, including balancing hormones, supercharging sex drive, cultivating intimacy and connection, optimizing nutrition and fitness, and boosting fertility.

The summit will consist of 24 video slideshow presentations, including talks by Dr. Sara Gottfried, Paul Check, Jane Bennett, Elliot Hulse, Dr. Jen Landa and yours truly. The title of my talk is “How Stress Sabotages Your Sex Drive—And What to Do About It.” I’ll discuss the intricate connections between the thyroid, adrenals and ovaries/gonads in both men and women, and how imbalances in one system can lead to dysfunction in the others. Here’s a sampling of other presentations that will be available:

Get in the Mood, Stay in the Mood by Dan KalishLow T: Causes, Symptoms and Solutions by Reed Davis50 Shades of Better Sex: Secrets of a Harvard Gynecologist by Dr. Sara GottfriedNatural Birth Control Alternatives by Jane BennettChasing the Big O: Overcoming the Inability to Orgasm by Cynthia Pasquella

In case you’re not familiar with the online summit format, here’s how it works. The summit startstakes place over six days, beginning on May 19th and concluding on May 26th. Each day will feature three to four presentations, which can be watched for FREE during a 24-hour period (9am to 9am Pacific). At 9am each morning, the previous day’s presentations are taken down and the next day’s go up. This means you can watch the entire event free of charge. Pretty cool, huh?

Sean is kicking the SexyBack Summit off with some cool free videos covering the top 5 ways to supercharge your sex drive. There’s a video for men (with functional medicine expert Reed Davis), and another for women (with celebrity nutritionist Cynthia Pasquella). To watch the videos and register (for free) for the Summit, just CLICK HERE.

If you’re subscribed to my email list, I’ll send out an email the day before my talk (which is happening on Day 6). I’ll also post reminders on Facebook and Twitter.

I hope you enjoy the Summit!

Note: I may earn a commission if you use the links in this article to purchase any products or programs I mentioned. I only recommend products I would use myself or that I use with patients in my practice. Your purchase helps support this site and my ongoing research.

Chris Kresser I hate spam too. Your email is safe with me.

Follow Chris Online:

Personal Paleo Code icon

Discover your own ideal diet & end confusion about what to eat forever.

Learn More healthy Baby Code icon

Boost fertility naturally & promote lifelong health for you & your baby.

Learn More Personal Paleo Launchpad icon

Personalized online portal with easy-to-use tools, expert advice, and the support of a passionate, intelligent community.

Learn More Paleologix icon

Break through the energy swings, digestive upset, and obstacles of adopting a Paleo diet.

Learn More

View the original article here

Recipe: Asparagus with Lemon and Almond

asparagusA beautiful side dish with a small ingredient list that packs great flavor.

Type of dish: Side Dish
Equipment: Pot with steamer basket and lid, sauté pan
Servings: Makes 4 servings.

2 to 2 1/2 pounds asparagus, washed, tough bottom parts broken off, and sliced into one-inch pieces1 TB traditional fat of choice5 cloves garlic, minced or pressed1/2 cup almonds, sliced or roughly choppedjuice of one lemonsalt to tasteSteam asparagus in covered pot with steamer basket, with one to two” of boiling water, until bright green, about 5 minutes.Remove asparagus from heat and drain any excess water.In a sauté pan, heat the oil over medium heat. Add the garlic and cook for one minute, stirring.Add the almonds and toast lightly, stirring for about another minute.Remove pot from heat and add in the steamed asparagus. Stir well.Finally squeeze in the juice of the lemon and salt to taste. Serve.

Enjoy!

Chris Kresser I hate spam too. Your email is safe with me.

Follow Chris Online:

Personal Paleo Code icon

Discover your own ideal diet & end confusion about what to eat forever.

Learn More healthy Baby Code icon

Boost fertility naturally & promote lifelong health for you & your baby.

Learn More Personal Paleo Launchpad icon

Personalized online portal with easy-to-use tools, expert advice, and the support of a passionate, intelligent community.

Learn More Paleologix icon

Break through the energy swings, digestive upset, and obstacles of adopting a Paleo diet.

Learn More

View the original article here

The Diet-Heart Myth: Statins Don’t Save Lives in People Without Heart Disease

statins

To read more about heart disease and cholesterol, check out the special report page.

Cardiovascular disease is one of the most misdiagnosed and mistreated conditions in medicine. In the first article in this series, I explained the evidence suggesting that eating cholesterol and saturated fat does not increase the risk of heart disease. In the second article, I explained it’s not the amount of cholesterol in your blood that drives heart disease risk, but the number of LDL particles. In the third article, I discussed the five primary causes of elevated LDL particle number.

In this article, I will debunk the myth that statin drugs save lives in healthy people without heart disease, and discuss some of the little known side effects and risks associated with these drugs.

Statins have been hailed by many in the conventional medical establishment as wonder drugs, with some physicians going as far as suggesting they should be added to the water supply. (The doctor that made that particular suggestion is named John Reckless – I kid you not.) But are statins really the wonder drugs they’ve been made out to be?

Are statins really the wonder drugs they’ve been made out to be?Tweet This

Before we dive into the statistics on statins, I need to briefly explain the difference between relative and absolute risk reduction. Researchers and pharmaceutical companies often use relative risk statistics to report the results of drug studies. For example, they might say “in this trial, statins reduced the risk of a heart attack by 30%”. But what they may not tell you is that the actual risk of having a heart attack went from 0.5% to 0.35%. In other words, before you took the drug you had a 1 in 200 chance of having a heart attack; after taking the drug you have a 1 in 285 chance of having a heart attack. That’s not nearly as impressive as using the 30% relative risk number, but it provides a more accurate picture of what the actual, or “absolute” risk reduction is.

With that in mind, let’s take a closer look at the efficacy of statins in two broad groups of people: those with pre-existing heart disease, and those without pre-existing heart disease. In the medical literature, these groups are referred to as “secondary prevention” and “primary prevention”, respectively.

There’s little doubt that statins are effective in reducing heart attacks and deaths from heart disease in people who already have heart disease. Several large controlled trials including 4S, CARE, LIPID, HPS, TNT, MIRACL, PROV-IT and A to Z have shown relative risk reductions between 7% on the low end in MIRACL and 32% on the high end in 4S, with an average risk reduction of about 20%.

However, absolute risk reductions are much more modest. They range from 0.8% in MIRACL on the low end to 9% in 4S on the high end, with an average of 3%.

An analysis by Dr. David Newman in 2010 which drew on large meta-analyses of statins found that among those with pre-existing heart disease that took statins for 5 years (1):

96% saw no benefit at all1.2% (1 in 83) had their lifespan extended (were saved from a fatal heart attack)2.6% (1 in 39) were helped by preventing a repeat heart attack0.8% (1 in 125) were helped by preventing a stroke0.6% (1 in 167) were harmed by developing diabetes10% (1 in 10) were harmed by muscle damage

A heart attack or stroke can have a significant negative impact on quality of life, so any intervention that can decrease the risk of such an event should be given serious consideration. But even in the population for which statins are most effective—those with pre-existing heart disease—83 people have to be treated to extend one life, and 39 people have to be treated to prevent a repeat heart attack.

Moreover, these results do not apply to all populations across the board. Most studies have shown that while statins do reduce cardiovascular disease (CVD) events and deaths from CVD in women, they do not reduce the risk of death from all causes (“total mortality”). (2)

Nor do these results apply to men or women over the age of 80. Statins do reduce the risk of heart attack and other CVD events in men over the age of 80, and especially at this age, these events can have a significant negative impact on quality of life. However, the bulk of the evidence suggests that statins don’t extend life in people over 80 years of age, regardless of whether they have heart disease, and the highest death rates in people over 80 are associated with the lowest cholesterol levels. (3), (4)

Statins do reduce the risk of cardiovascular events in people without pre-existing heart disease. However, this effect is more modest than most people assume. Dr. Newman also analyzed the effect of statins given to people with no known heart disease for 5 years (5):

98% saw no benefit at all1.6% (1 in 60) were helped by preventing a heart attack0.4% (1 in 268) were helped by preventing a stroke1.5% (1 in 67) were harmed by developing diabetes10% (1 in 10) were harmed by muscle damage

These statistics present a more sobering view on the efficacy of statins in people without pre-existing heart disease. They suggest that you’d need to treat 60 people for 5 years to prevent a single heart attack, or 268 people for 5 years to prevent a single stroke. These somewhat unimpressive benefits must also be weighed against the downsides of therapy, such as side effects and cost. During that hypothetical 5 year period, 1 in 67 patients would have developed diabetes and 1 in 10 patients would have developed muscle damage (which can be permanent in some cases, as we’ll see later in this section).

In addition, while statins do moderately reduce cardiovascular events such as heart attack in people without heart disease, they’ve never been shown to extend lifespan in this population. This is true even when the risk of heart disease is high. In a large meta-analysis of 11 randomized controlled trials by Kausik Ray, MD and colleagues published in the Archives of Internal Medicine, statins were not associated with a significant reduction in the risk of death from all causes. (6)

This trial included 65,000 people without pre-existing heart disease but with intermediate to high risk of heart disease. It was important because it was the first review that only included participants without known heart disease. Previous studies suggesting that statins are effective in reducing death in people without pre-existing heart disease included some people that did have heart disease, which would have skewed the results.

The lack of significant effect on mortality is even more interesting in light of the fact that LDL cholesterol levels did decrease significantly in the statin group; the average LDL level in those taking placebo was 134 mg/dL and the average in the statin-treated patients was 94 mg/dL—roughly 30% lower. Yet in spite of this marked reduction in LDL cholesterol in the statin group, there was no difference in lifespan between the two groups. This is yet another line of evidence suggesting that the amount of cholesterol in LDL particles is not the driving factor in heart disease.

A meta-analysis of statin trials in people without heart disease by the prestigious Cochrane Collaboration came to a similar conclusion. (7) They also observed that all but one of the clinical trials providing evidence on this issue were sponsored by the pharmaceutical industry. This is significant because research clearly indicates that industry-sponsored trials are more likely than non-industry-sponsored trials to report favorable results for drugs because of biased reporting, biased interpretation, or both. (8)

If statins were harmless and free, then it wouldn’t matter how many people need to be treated to prevent a heart attack or extend someone’s lifespan. But statins are not free, nor are they harmless. Statin use has been associated with a wide range of side effects, including myopathy (muscle pain), liver damage, cataracts, kidney failure, cognitive impairment, impotence and diabetes.

Unfortunately, studies show that physicians are more likely to deny than affirm the possibility of statin side effects, even for symptoms with strong evidence in the scientific literature. (9) Assuming that physicians would likely not report the adverse reaction in these circumstances, it’s probable that the incidence of statin side effects is much higher than the reported rates.

One of the most troubling side effects of statins that has only recently become apparent is their potential to increase the risk of diabetes, especially in women. A study by Dr. Naveed Sattar and colleagues published in The Lancet in 2010 examined 13 randomized clinical trials involving over 90,000 patients taking statins. They found that statin use was associated with a 9% increased risk in developing diabetes. Note that this is a relative risk, so the absolute risk of developing diabetes while taking a statin is very low. That said, observational data from the Women’s Health Initiative found a 48% increased risk of diabetes in healthy women taking statins after adjusting for other risk factors. (10)

To summarize:

The only population that statins extend life in are men under 80 years of age with pre-existing heart disease.In men under 80 without pre-existing heart disease, men over 80 with or without heart disease, and women of any age with or without heart disease, statins have not been shown to extend lifespan.Statins do reduce the risk of cardiovascular events in all populations. A heart attack or stroke can have a significant, negative impact on quality of life—particularly in the elderly—so this benefit should not be discounted.However, the reductions in cardiovascular events are often more modest than most assume; 60 people with high cholesterol but no heart disease would need to be treated for 5 years to prevent a single heart attack, and 268 people would need to be treated for 5 years to prevent a single stroke.Statins have been shown to cause a number of side effects, such as muscle pain and cognitive problems, and they are probably more common than currently estimated due to under-reporting.

My intention here is not to suggest that statins have no place in the treatment of heart disease, but rather to give you the objective information you need to decide (along with your doctor) whether they are appropriate for you. The decision whether to take them should be based on whether you have pre-existing heart disease, what your overall risk of a heart attack is, how healthy your diet and lifestyle is, what other treatments you’ve already tried, and your own risk tolerance and worldview. It’s clear that statins reduce heart disease as well as the risk of death in those that have already had a heart attack, so if you’re in this group and you’ve already tried diet and lifestyle interventions without much impact on your lipid or inflammatory markers, you are more likely to benefit.

In the next and final article of this series, I’ll discuss three steps to preventing and reversing heart disease naturally, without drugs.

Tagged as: cardiovascular, cholesterol, drugs, Heart Disease, myths, statins, treatment

Chris Kresser I hate spam too. Your email is safe with me.

Follow Chris Online:

Personal Paleo Code icon

Discover your own ideal diet & end confusion about what to eat forever.

Learn More healthy Baby Code icon

Boost fertility naturally & promote lifelong health for you & your baby.

Learn More Personal Paleo Launchpad icon

Personalized online portal with easy-to-use tools, expert advice, and the support of a passionate, intelligent community.

Learn More Paleologix icon

Break through the energy swings, digestive upset, and obstacles of adopting a Paleo diet.

Learn More

View the original article here

The Diet-Heart Myth: Cholesterol and Saturated Fat Are Not the Enemy

butter heart

To read more about heart disease and cholesterol, check out the special report page.

It’s hard to overstate the impact that cardiovascular disease (CVD) has in the U.S.. Consider the following:

Cardiovascular disease affects 65 million Americans.Close to one million Americans have a heart attack each year.In the U.S., one person dies every 39 seconds of cardiovascular disease.1 of 3 deaths that occurs in the U.S. is caused by cardiovascular disease.1 in 3 Americans have metabolic syndrome, a cluster of major cardiovascular risk factors related to overweight/obesity and insulin resistance.The total cost of cardiovascular disease in 2008 was estimated at $300 billion.

To put that last statistic in perspective, the World Health Organization has estimated that ending world hunger would cost approximately $195 billion. One might argue that the $300 billion we spend on treating cardiovascular disease in the U.S. is a necessary expenditure; however, a recent study which looked at the relationship between heart disease and lifestyle suggested that 90% of CVD is caused by modifiable diet and lifestyle factors. (1)

Unfortunately, cardiovascular disease is one of the most misdiagnosed and mistreated conditions in medicine. We’ve learned a tremendous amount about what causes heart disease over the past decade, but the medical establishment is still operating on outdated science from 40-50 years ago.

In this 4-part series, I’m going to debunk 3 common myths about heart disease:

Eating cholesterol and saturated fat raises cholesterol levels in the blood.High cholesterol in the blood is the cause of heart disease.Statins save lives in healthy people without heart disease.

In the fourth and final article in the series, I’ll discuss strategies for naturally protecting yourself against heart disease.

Most of us grew up being told that foods like red meat, eggs and bacon raise our cholesterol levels. This idea is so deeply ingrained in our cultural psyche that few people even question it. But is it really true?

The diet-heart hypothesis—which holds that eating cholesterol and saturated fat raises cholesterol in our blood—originated with studies in both animals and humans more than half a century ago. However, more recent (and higher quality) evidence doesn’t support it.

Cholesterol and saturated fat: dietary enemies or innocent victims of bad science?Tweet This

On any given day, we have between 1,100 and 1,700 milligrams of cholesterol in our body. 25% of that comes from our diet, and 75% is produced inside of our bodies by the liver. Much of the cholesterol that’s found in food can’t be absorbed by our bodies, and most of the cholesterol in our gut was first synthesized in body cells and ended up in the gut via the liver and gall bladder. The body tightly regulates the amount of cholesterol in the blood by controlling internal production; when cholesterol intake in the diet goes down, the body makes more. When cholesterol intake in the diet goes up, the body makes less.

This explains why well-designed cholesterol feeding studies (where they feed volunteers 2-4 eggs a day and measure their cholesterol) show that dietary cholesterol has very little impact on blood cholesterol levels in about 75% of the population. The remaining 25% of the population are referred to as “hyper-responders”. In this group, dietary cholesterol does modestly increase both LDL (“bad cholesterol” and HDL (“good cholesterol”), but it does not affect the ratio of LDL to HDL or increase the risk of heart disease. (2)

In other words, eating cholesterol isn’t going to give you a heart attack. You can ditch the egg-white omelettes and start eating yolks again. That’s a good thing, since all of the 13 essential nutrients eggs contain are found in the yolk. Egg yolks are an especially good source of choline, a B-vitamin that plays important roles in everything from neurotransmitter production to detoxification to maintenance of healthy cells. (3) Studies show that up to 90% of Americans don’t get enough choline, which can lead to fatigue, insomnia, poor kidney function, memory problems and nerve-muscle imbalances. (4)

What about saturated fat? It’s true that some studies show that saturated fat intake raises blood cholesterol levels. But these studies are almost always short-term, lasting only a few weeks. (5) Longer-term studies have not shown an association between saturated fat intake and blood cholesterol levels. In fact, of all of the long-term studies examining this issue, only one of them showed a clear association between saturated fat intake and cholesterol levels, and even that association was weak. (6)

Moreover, studies on low-carbohydrate diets (which tend to be high in saturated fat) suggest that they not only don’t raise blood cholesterol, they have several beneficial impacts on cardiovascular disease risk markers. For example, a meta-analysis of 17 low-carb diet trials covering 1,140 obese patients published in the journal Obesity Reviews found that low-carb diets neither increased nor decreased LDL cholesterol. However, they did find that low-carb diets were associated with significant decreases is body weight as well as improvements in several CV risk factors, including decreases in triglycerides, fasting glucose, blood pressure, body mass index, abdominal circumference, plasma insulin and c-reactive protein, as well as an increase in HDL cholesterol. (7)

If you’re wondering whether saturated fat may contribute to heart disease in some way that isn’t related to cholesterol, a large meta-analysis of prospective studies involving close to 350,000 participants found no association between saturated fat and heart disease. (8) A Japanese prospective study that followed 58,000 men for an average of 14 years found no association between saturated fat intake and heart disease, and an inverse association between saturated fat and stroke (i.e. those who ate more saturated fat had a lower risk of stroke). (9)

That said, just as not everyone responds to dietary cholesterol in the same manner, there’s some variation in how individuals respond to dietary saturated fat. If we took ten people, fed them a diet high in saturated fat, and measured their cholesterol levels, we’d see a range of responses that averages out to no net increase or decrease. (If dietary saturated fat does increase your total or LDL cholesterol, the more important question is whether that’s a problem. I’ll address that in the next article in this series.)

Another strike against the diet-heart hypothesis is that many of its original proponents haven’t believed it for at least two decades. In a letter to the New England Journal of Medicine in 1991, Ancel Keys, the founder of the diet-heart hypothesis said (10):

Dietary cholesterol has an important effect on the cholesterol level in the blood of chickens and rabbits, but many controlled experiments have shown that dietary cholesterol has a limited effect in humans. Adding cholesterol to a cholesterol-free diet raises the blood level in humans, but when added to an unrestricted diet, it has a minimal effect.

In a 2004 editorial in the Journal of American College of Cardiology, Sylvan Lee Weinberg, former president of the American College of Cardiology and outspoken proponent of the diet-heart hypothesis, said (11):

The low-fat, high-carbohydrate diet… may well have played an unintended role in the current epidemics of obesity, lipid abnormalities, type 2 diabetes, and metabolic syndromes. This diet can no longer be defended by appeal to the authority of prestigious medical organizations.

We’ve now established that eating cholesterol and saturated fat does not increase cholesterol levels in the blood for most people. In the next article, I’ll debunk the myth that high cholesterol in the blood is the cause of heart disease.

Tagged as: cholesterol, heart attack, Heart Disease, myths, saturated fat

Chris Kresser I hate spam too. Your email is safe with me.

Follow Chris Online:

Personal Paleo Code icon

Discover your own ideal diet & end confusion about what to eat forever.

Learn More healthy Baby Code icon

Boost fertility naturally & promote lifelong health for you & your baby.

Learn More Personal Paleo Launchpad icon

Personalized online portal with easy-to-use tools, expert advice, and the support of a passionate, intelligent community.

Learn More Paleologix icon

Break through the energy swings, digestive upset, and obstacles of adopting a Paleo diet.

Learn More

View the original article here

RHR: Early Evidence For Meat Consumption, The Cholesterol Controversy, and Additional Magnesium Sources

the podcast logo

In this episode I discuss a couple of interesting recent studies, and answer some questions. Enjoy!

In this episode, we cover:

1:35 What Chris ate for breakfast
6:27 Early evidence for meat consumption
18:33 Solving the cholesterol controversy
38:22 More details from Chris’s daily routine (and more treadmill desk)
44:00 Additional sources of magnesium
48:35 When should I stop breastfeeding?
52:49 What to do about anxiety during pregnancy

Podcast: Play in new window | Download

Steve Wright:  Hey everyone, welcome to another episode of the Revolution Health Radio Show.  This show is brought to you by ChrisKresser.com, and I’m your host, Steve Wright from SCDLifestyle.com.  With me is integrative medical practitioner and healthy skeptic Chris Kresser.  Chris, how are you doing today?

Chris Kresser:  I’m great, Steve.  It’s absolutely gorgeous today.  It’s been gorgeous the last several days, like in the high 70s, low 80s.  I’ve just been spending a lot of time outside with Sylvie, going on walks in the woods near my house.  Having grown up in Southern California and being used to 300 days of sunshine a year, I have to say this is happy weather for me!

Steve Wright:  Yeah, I actually just got back from a little vacation to Colorado, and even though while I was there it was everything from 25 degrees all the way to 80, it was sun shining every day, and it was the most sun I have seen in the last six months.

Chris Kresser:  Yeah, that’s the thing about Colorado, huh?  It’s very sunny there even when it’s freezing cold a lot of the time in the winter.

Steve Wright:  Yeah, it was beautiful.

Chris Kresser:  Great.  So I think it’s going to be another Q&A show today, but I have a couple studies we’re going to talk about first.

Steve Wright:  OK, well, before we get into the studies, did you have anything special for breakfast today?

Chris Kresser:  Well, I don’t know if it’s special.  I liked it.  I had two duck crépinettes.

Steve Wright:  A what?

Chris Kresser:  A crépinette.

Steve Wright:  Oh.

Chris Kresser:  This is from the charcuterie that I frequent at the farmers’ market.  It’s called The Fifth Quarter.  This guy Scott makes fantastic sausages and salamis and duck and liver pâtes and all kinds of artisanal meats.  And I may get this wrong in terms of the precise description, but a crépinette is like a patty of meat and spices that’s then wrapped in pork fat.  So I just cooked them in a pan.  These ones were duck.  He also makes some lamb crépinettes and, I think, pork crépinettes as well.  They’re really tasty.  They’re amazing.  And then I had some taro sliced really thin with a mandolin and roasted in a little bit of duck fat.  And I had some steamed broccoli with a little bit of olive oil and then a little bit of beet kvass to wash it all down.

Steve Wright:  Sounds pretty gourmet.

Chris Kresser:  It was good.  I’m doing my two-meal-a-day thing today.  It just seems to be the pattern I’m in right now, and it’s working for me.

Steve Wright:  Awesome.  Well, whenever you want to invite me over for breakfast, I’ll try one of these crépinettes.

Chris Kresser:  Anytime.  I think you’d like it.

Steve Wright:  Well, anything wrapped in pork fat, I think, is a hit for myself or anyone listening to this show.

Chris Kresser:  It’s hard to argue with, huh?

Steve Wright:  Yeah.  OK, well, before we get rolling into the studies, I want to tell everybody about Beyond Paleo, Chris.  So I don’t know if you need to… We’re not in the closet today, right?

Chris Kresser:  That’s right.  We’re out of the closet.  I’m committed to making the audio as good as I possibly can, but I discovered there’s a limit to that commitment.  However, I will say that one of our listeners, Mike, stepped up.  He has a lot of audio experience, and he generously donated a lot of his time to explaining several different ideas.  First of all, he said the audio for our show is great, and that’s a testament to you and Jordan and all the help you guys have given me in making this a fantastic show already.  But he said there were a few things we could do just to reduce the echo, which is kind of the main problem that some people have noticed.  So I bit the bullet, bought some extra sound-dampening equipment that I can set up.  I don’t have it yet.  It’s going to be here in time for the next show.  And I think once we get that set up, the audio is just going to be perfect, so I’m excited about that.  And I’m excited to be back in my office overlooking the redwood trees.  It’s much more picturesque than the closet, I’ll tell you.

Steve Wright:  Than a t-shirt?

Chris Kresser:  Yeah.

Steve Wright:  OK, awesome.  Well, huge thanks to Mike, and we’re doing our best to make this the best sounding as well as the best content on the web.  Chris, go ahead and take a break here.  I want to tell everyone about Beyond Paleo.  So if you’re new to this podcast, if you’re new to the paleo diet, or maybe you’re just someone who’s interested in optimizing your health, you’re going to want to check out what over 30,000 other people have already signed up for and started to read.  It’s called Beyond Paleo, and it’s a free 13-part email series on burning fat, boosting energy, and preventing and reversing disease without drugs.  To sign up, head over to ChrisKresser.com, and look for the big red box.  In that box, go ahead and enter your name and your email address, and Chris will go ahead and ship off the first email to your right away.  It’s pretty awesome.  I would highly recommend you start reading this series right away.

Chris, if people want more info from you in between podcasts, they can head over to Facebook and Twitter, right?

Chris Kresser:  That’s right.  Yeah, Facebook, I have a really vibrant community there, lots of great discussion.  I post a lot of studies and just things I’m thinking about throughout the week that don’t make it to my blog, and I do the same thing on Twitter.  So definitely join us there if you’re on Facebook and Twitter.

Steve Wright:  And to get there, if you’re just listening to this on iTunes, go to Facebook.com/ChrisKresserLAc or Twitter.com/ChrisKresser.

Chris Kresser:  All right.

Steve Wright:  Let’s do some studies!

Chris Kresser:  Yeah.  Those of you who follow me on Facebook and Twitter may have already seen my link to these studies, but there was one anthropological study I want to talk about that John Hawks, an anthropologist whose blog I follow and some of you may, reported on earlier in the week.  The earliest evidence of humans butchering animals for meat with stone tools is about 2.6 million years old, and that’s kind of the background for this study.  But the issue with that is that a lot of that could have been scavenging kills from other animals.  So instead of humans purposefully hunting the animals themselves and then eating them, they came across a carcass from an animal that had been hunted by some other prey animal, like a lion, for example.  That in a lot of ways, as John Hawks pointed out, is no less impressive because presumably humans were having to, in many cases, compete with these other animals for the carcass, whether the animals were there at the time or they came back, so it’s still a pretty amazing testament to the collective intelligence and teamwork of our distant ancestors.  But there were a lot of questions still then about whether we were hunting animals ourselves versus just encountering the carcasses that had already been killed.

The first really good evidence for actual hunting is about 1.8 million years old, and that was found at the Olduvai Gorge in Tanzania.  This new study that John Hawks talked about has made a big contribution to our understanding in this area because it analyzed fossil remains from Kenya, from Kandera South, which is an assemblage of artifacts and animal bones from about 2 million years ago.  And this was during what’s referred to as the Oldowan period, which is the earliest stone tool industry, which lasted from about 2.6 million years ago to about 1.7 million years ago.  Now, what was different about this study compared to some of the other ones that have been done before is that the researchers used some pretty smart methods to determine that the animal bones that were found at the site were from animals that were actually hunted and killed by humans rather than scavenged.  And they did this by looking at tooth and cut marks on the bones.  Carnivores who get to chew on bones for a while once they kill an animal, they tend to leave the middle of the bones covered in tooth marks, but if humans get access to the carcass early, they strip off the meat from the midshafts, and then they break those shafts into bits, which leaves different marks on the bones.  So in this study, they compared the tooth and cut marks on the bones that they found, and at this particular site they found marks that were much more consistent with what happens when humans get access to the carcass first, which, of course, suggested that humans had hunted and killed these animals.

Another interesting finding in this study is how our ancestors ate the animals that they killed.  A lot of these animals were really too large to carry in their entirety back to a central place like a cave, campsite, living area where they could all share it.  So what they did is they dismembered the animals on-site where they were hunted, and they only carried back certain parts of the animals, which would, of course, been the parts that were favored and easier to transport.  The parts that they brought back were the legs and the heads, and then they left the rest of the body behind.  So the legs are pretty obvious.  Those of us who eat meat often eat the legs of animals, and they’re some of the best parts there.  But the heads may not be as obvious at least at first glance, but I’ll read from a quote from the paper to explain why they did this, so it says:

But why acquire, transport, and process an abundance of medium-sized heads?  In living animals, these remains contain a wealth of fatty, calorie-packed, nutrient-rich tissues: a rare and valuable food resource in a grassland setting where alternate high-value foodstuffs (fruits, nuts, etc.) are often unavailable.

So essentially the heads contain brains, and brains are very rich in fatty acids, and in particular, the long-chain omega-3 fat DHA, which increasing evidence suggests is essential, meaning not only very important, but the technical definition of essential here from a dietary perspective means a nutrient that we need for proper functioning but cannot synthesize in our body.  Now, historically the shorter chained omega-3, primarily plant-based fat has been considered essential.  That’s alpha-linolenic acid, and it’s found in flaxseeds and walnuts, mostly nuts and seeds.  And it’s true that some alpha-linolenic acid can be converted into DHA, but that conversion is extremely poor in most people.  In fact, in the average person, less than 0.5%, or one-half of 1%, of alpha-linolenic acid gets converted into DHA.  And that’s in relatively healthy people.  That conversion is dependent on enzymes that in turn require adequate amounts of certain nutrients, like B6 and zinc, and a lot of Americans — I think up to about one-third of Americans — are deficient in the nutrients that are involved in that enzymatic conversion.  And especially vegans and vegetarians tend to have higher levels of deficiency of those nutrients.  So that one-half of 1% is kind of a best-case figure.  In reality, it’s probably a lot less than that.  And the problem there is that alpha-linolenic acid has not been shown to have the same benefits as the long-chain omega-3 fats, like EPA and particularly DHA.  So you have a situation where we need DHA, and yet even though in theory we can convert some of the shorter chained fats into DHA, in practice, especially amongst people with chronic illness or any nutrient deficiencies at all, which are really common, very little gets converted into DHA.  So what this suggests is that DHA is really, rather than alpha-linolenic acid, the real essential omega-3 fat.

This research in some way contributes to our understanding of why this might be.  I mean, we might wonder, why is that conversion so poor?  Well, if our ancestors were eating a lot more DHA, preformed DHA, like from the brains of animals that they hunted or from fish, for example, then the need to make that conversion from the short-chain omega-3 fat into DHA would have been a lot less.  And in fact, most studies do suggest that this is true.  Historically speaking, our ancestors’ intake of DHA — and for that matter, the long-chain omega-6 fat, which is arachidonic acid — our ancestors’ intake of those longer chained polyunsaturated fats was much higher than our average intake today, so it’s very likely that they didn’t really have a need to make those conversions.

This is an interesting study for me for a number of different reasons, both the evidence that we were hunting and not just scavenging animals as long ago as 2 million years ago and that we were eating the brains, which implies that we had a significant source of long-chain omega-3 fats, which could explain some of the problems we see in the conversion and adds some data to the idea that DHA rather than alpha-linolenic acid is essential.  Now, of all of the reasons that I think vegan and vegetarian diets aren’t optimal for many people for long-term health, this is probably one of the biggest because DHA is so important to the function of the brain and our vision and the growth and development of the fetus, and it just plays so many important roles that a diet that doesn’t have any preformed DHA, which a vegetarian and vegan diet would not, is really kind of difficult to support from a nutritional perspective.  This doesn’t, of course, address the various ethical and perhaps social reasons or religious reasons that people might choose to do a vegetarian or vegan diet, but I’m just speaking right now in terms of a nutritional perspective.  Vegans and vegetarians, I highly recommend taking an algae supplement.  Algae is where fish get DHA from, so it does contain preformed DHA, certain types of microalgae.  It has to specifically be for DHA.  There are a few out there.  Unfortunately, they’re quite expensive, and you have to take a lot of it to get the recommended amount of DHA, but it’s better than not taking any at all.

Let’s see if I have anything else to say about that study… Yeah, I don’t think so.  That’s it for that.

Steve Wright:  It think it’s an awesome new piece of research to definitely add to, I guess, our stack of research that supports all the recommendations we always make on this show.  I really appreciate you just going through that study, so thanks, Chris.

Chris Kresser:  Yeah.  I’m fascinated by medical anthropology, and if I could go back to college now, I would probably study medical anthropology.  It’s a really interesting subject to me, and I think it has a lot to teach us as well.

The second study I wanted to talk about is actually a paper published in the journal Circulation, and it made kind of a big splash, at least within the research community, so some of you might have seen it already.  But this paper, what they were trying to do is determine which measures of cholesterol and lipoproteins are most predictive for a future risk of heart attack in a very high-risk population.  I’ve actually been writing a series on the blog the last couple of weeks about this, about cholesterol and lipoproteins and the difference between the two and which tests are best in terms of predicting your heart disease risk.  And there’s a fair amount of controversy still in this area, and some studies, for example, in the past have shown that the ratio of total cholesterol/HDL is just as good as a marker as LDL particle number, which is the number of LDL particles that are actually moving around in the bloodstream.  And then there have been a lot of other studies that have shown that LDL particle number or ApoB, which is a kind of proxy marker for LDL particular number, are much better predictors of risk.  So that’s what this study was setting out to look at, that question.

What made this a little bit different than some previous studies that have been done in this area is that the previous studies were observational in nature, so they were looking at observational or epidemiological data, and this study looked at data from a randomized clinical trial that was done.  This particular trial was the Medical Research Council/British Heart Foundation Heart Protection Study, and it was 20,000 high-risk men and women, and they followed them for an average of five years.  And the original trial was actually looking at the effect of a statin drug versus an antioxidant, but they measured a whole bunch of stuff, as they often do in randomized clinical trials, so in this paper the researchers just harvested some of that data.  They looked at levels of total cholesterol, LDL cholesterol, HDL, total cholesterol/HDL ratio, and then all of the different lipid subfractions like LDL particle number.  They looked at LDL particle size, you know, small LDL versus large LDL.  They looked at HDL particle number, HDL size, so they had a lot of information to work with.  And what they found in this study was that all of the LDL measurements were equally predictive for a heart attack in this high-risk population, so LDL cholesterol, LDL particle number, and ApoB, which again is a kind of proxy for measuring LDL particle number, were all relatively similar in terms of their ability to predict a heart attack in the future.

They also found that HDL was a lot less predictive, particularly in those that had pre-existing heart disease, and this is interesting, this has come up before in other studies, and what it suggests — and what some other research also suggests — is that the function of HDL decreases in people with heart disease, so there’s kind of a reverse causality there.  And one of the reasons we might see low HDL or low HDL particle number or even a normal HDL particle number but increased risk of heart disease or higher incidence of heart attack in people that have already had heart disease is that the heart disease itself actually weakens the function of HDL so it can’t carry out its protective function as well as it does in someone that doesn’t have heart disease.  So that was interesting.

And in this study there was a much stronger correlation between LDL cholesterol and LDL particle number.  As I wrote in a recent article on my website, LDL cholesterol and LDL particle number are sometimes related.  They’re often related, but not always.  And in fact, in people with metabolic syndrome, insulin resistance, they can have normal or even low levels of total and LDL cholesterol and high LDL particle number, in which case they’ll be at increased risk.  So this study showed a correlation of about 0.79, which is quite strong.  It’s certainly not perfectly correlated, but it’s stronger than the correlation that has been observed in previous studies, which was closer to 0.6.  It was 0.62 or 0.63, I think.  So the data in this is a little bit different in terms of the relationship between LDL cholesterol and LDL particle number.

There was an accompanying editorial in the journal about this study, and it was written by a doctor, and his main point is that we don’t need these extra fancy tests for estimating heart disease risk because this study shows that the standard markers are just fine in terms of predictive value.  And the other point he makes is that most people who have a heart attack have at least one risk factor.  It doesn’t just happen out of the blue.  He points to a study that looked at 21,000 deaths from fatal heart attacks, and exposure to at least one clinically elevated major risk factor was present in 87% to 100% of the people who died from a heart attack, and ‘risk factor’ in this study was defined as total cholesterol of at least 240 mg/dL, systolic blood pressure of 140, diastolic blood pressure of at least 90, cigarette smoking, and clinical diabetes.  So one of those was present in 87% to 100% of people who had a fatal heart attack, the point being that we kind of know already what the risk factors are for heart disease.  The basic lipid markers that we have are sufficient, so we don’t really need to do any more advanced testing.

I definitely agree with parts of that analysis.  I do think, as I’ve argued many times, that heart disease is a complex, multifactorial process and that it’s heavily influenced by lifestyle factors.  There was the famous INTERHEART study that looked at heart disease in over 50 countries around the world, and they found that 9 out of 10 heart attacks could have been prevented by modifiable diet and lifestyle factors, which, similar to the statistics here, it suggests that maybe 1 in 10 heart attacks are due primarily to genetics or maybe some other lifestyle or diet factor that wasn’t measured, like perhaps chronic stress or maybe gut dysbiosis or some kind of emerging factor that we don’t fully understand yet how it contributes and that isn’t often easy to measure and isn’t often measured in these studies.  So I definitely agree with that.

Also, as I pointed out in the High Cholesterol Action Plan, the ratio of total cholesterol/HDL is often in a general sense, or we should say on average, it’s just as predictive as LDL particle number, but the problem is we don’t treat averages in the clinic.  I mean, any clinician knows this.  We treat individual patients.  So studies are really good at determining trends and average effects.  They take a whole bunch of people, they measure what happened, and they average out the results and come up with a basic finding that then can be applied to clinical settings, and that’s how research is used to make treatment decisions and determine what the standard of care is.  And I’m not suggesting that I have a better way to do it, necessarily, but what I am saying is that there are always outliers on either side of the equation.  And in fact, in the editorial he says:  “It is useful to seek better discrimination of risk in those at the margins, but it is not where our greatest effort should be focused.”  And again, it’s true.  In most cases, most people just need to clean up their diet, clean up their lifestyle, get their blood pressure down, lose weight, improve their insulin sensitivity and glucose tolerance, and stop smoking.  You know, they need to take care of the basics.  That’s absolutely true.  But in the population of people that I work with, I’m hard-pressed to think of any of my patients, maybe two, that smoke cigarettes.  And many of my patients are not overweight significantly, they don’t have high blood pressure, they don’t have diabetes, they don’t fit this normal risk profile.  And yet some of them have very high LDL particle number with normal total cholesterol.  Some have high LDL particle number with high cholesterol.  Some have high cholesterol with normal LDL particle number.  So all of these situations are outside of what most doctors are seeing in their average clinical practice, and they deserve a different approach than those situations because a lot of the data that we have on the relationship between these lipid markers and heart disease doesn’t really necessarily apply to people that are on the margins, so to speak.

So I think this study adds some really important information in terms of determining a kind of general approach in standard practice, but I don’t think it invalidates the use of LDL particle number or some of the more advanced markers in one-on-one patient care, especially when someone has a more specialized practice and is treating people who are already pretty healthy, at least from a cardiovascular perspective, and are mostly interested in optimizing their health.

I will say, though, that one thing that has been really consistent in these studies is that LDL particle size does not add any predictive value once LDL particle number is known.  I think the confusion in the past where we did see these relationships between LDL particle size and heart disease is that at that time, LDL particle number was often not being measured, and so it appeared that the particle size was significant in terms of predictive value, but now when you adjust for LDL particle number, when you know the particle number, adding particle size doesn’t add any additional value.  Part of what helped us figure this out is the observation that people with familial hypercholesterolemia, which is a genetic condition that leads to very high LDL particle number and cholesterol levels, they often have large, buoyant, fluffy LDL, and yet they’re still at three times greater risk of death from heart disease than people without familial hypercholesterolemia.  So I think we can safely not worry too much about particle size as long as we know particle number, and as always, like most other diseases, heart disease is, as I said, complex and multifactorial.  There are a number of different things to consider when we’re determining the overall picture of risk.  I still think LDL particle number is a better lipid marker than LDL or total cholesterol or even the total/HDL cholesterol ratio, but total/HDL ratio for most people is a good surrogate for LDL particle number, and if you can’t afford to get or don’t have access to ApoB or LDL particle number, that can be a good substitute for many people.

Steve Wright:  Hey, Chris, let’s bring it really home for our listeners, if you can.  We just talked about total cholesterol, we talked about the ratio total/HDL, we talked about LDL-P.  Can you just give us your numbers that we should be trying to hit?  People are going to listen to this.  They’re probably going to get these things checked.  Our listeners are like your population, most likely, so can you give us some of your functional numbers for people to go after?

Chris Kresser:  Well, it’s quite complex.  I wish I could answer that question really simply.  Now, that’s part of the reason I ended up doing the High Cholesterol Action Plan, is that I realized that there was no simple way I can answer the question.  The course ended up being nine weeks long because it is really quite an involved process to determine your heart disease risk, and the reason I’ve been hesitant to just throw out a certain number is that it really varies in the sense that you have to consider the rest of the context.  Let’s say, for example, that I said you want your total cholesterol/HDL ratio to be under 4 — and that is a standard target — so if you divide your total cholesterol by HDL, it should be less than 4.  Some say less than 3 is much better and more optimal.  But let’s take two hypothetical people.  Let’s say one person has a total cholesterol/HDL ratio over 4, but they have no other risk factors for heart disease.  They’re in excellent shape, they’re fit, they exercise regularly, they’re physically active, they don’t sit a lot, they eat a really healthy diet, they manage their stress, they sleep well, etc.  They’re like the poster child for health except they have this ratio that’s above 4.  Maybe it’s 4.1 or 4.2.  And then you have another person who has the same exact total/HDL ratio, but they have high blood pressure, they’re obese, they’re not exercising, they’re not managing their stress, and they’re eating a standard American diet, and they’re 20 years older than the other people.  Obviously those two people are going to have really different heart disease risk, and even though their total/HDL ratio is the same, they’re not at all in the same boat.  And one person might need a lot of treatment, a crash course in diet changes, everything else.  The other person may not need any treatment at all, depending on the situation, maybe their family history and things like that.  So that’s kind of my hesitation, but the general target for total/HDL ratio is less than 4.

LDL particle number is really contextual, in my opinion.  I mean, the National Lipid Association and folks like Dr. Dayspring, who has written a lot about LDL particle number, and the NLA has been really responsible, to a large degree, for getting the word out there about LDL-P.  They want to see it below 1000, which is below the 20% percentile.  It’s separated into quintiles.  So if you’re below 1000, you’re in the zero to 20th percentile.  If you’re 1000 to 1299, I think, you’re in the 20th to 40th percentile.  If you’re 1300 to 1599, I think, you’re in the 40th to 60th.  1600 to — I may be getting this slightly wrong because I think I just missed — 1600 or 1700 to 1999, you’re in the 60th to 80th.  And then above 2000, you’re in the 80th to 100th percentile.  The NLA wants to see people below 1000, and they will medicate anybody with statins regardless of their other risk factors or their ‘picture.’  They’ll medicate anyone with a statin to get their LDL-P below 1000.  I’m not so sure that that’s necessary.  I think context does matter.  So if somebody comes to see me and they have an LDL-P of 1300, which puts them still in the sort of low moderate risk, maybe moderate risk group, if they have no other risk factors, I think it’s hard to justify medication in that situation, given the current evidence and what we know about the multifactorial nature of heart disease.  And as I just said, in people who had fatal heart attacks in the study that we talked about in the editorial, 87% to 100% of them had a major risk factor.  So I’m a little less aggressive as far as that goes and a lot more likely to look at the other factors.

Steve Wright:  OK, well, thanks for taking a shot at that.

Chris Kresser:  Sure.  So I think that’s it for that study.  We have time for a few questions now before we finish.

Steve Wright:  OK, let’s transition.  The first question that we have here comes from Laura, and she wants to know more about your standing desk, Chris.  She says that she has transitioned to a standing desk while at the corporate office and has the opportunity to use a treadmill desk as well.  “What are your thoughts on decompressing the spine after long periods of standing?  I’ve learned that in order to help improve recovery after endurance events that you should spend time upside down or with your feet up against a wall.  What are your thoughts on this related to long periods of standing?  If I work standing for 8 hours, should I end my day with 8 minutes of time lying on the ground with my legs vertically against the wall?  Is there anything that you would recommend doing to balance out the body after standing all day?”

Chris Kresser:  Yeah, that’s a good question.  Truthfully, this isn’t an area of expertise for me.  This might be something I would defer to my wife on.  She has a lot more advanced understanding of biomechanics and has spent a lifetime studying that.  She had a treadmill desk, right?  Not just the standing desk?

Steve Wright:  I think she says she has both.

Chris Kresser:  Um-hum.  So one thing I mentioned, I think, when we first started talking about treadmill desks is there’s actually some research that suggests that standing for long periods is not that beneficial and possibly harmful.  I’m not sure that standing for 8 hours is an improvement from a health… I think it probably is an improvement over sitting for 8 hours, but I think if your choice is standing desk or sitting desk, maybe a mixture of both, actually, throughout the day is a better idea than just standing for the entire day at the desk, based on what some of the research about standing for too long suggests.  I myself actually switch back and forth between several different postures and positions.  I have a standing desk, of course, and then I have the treadmill desk, and then I have a sitting desk with a really nice chair, a Herman Miller chair that I will often sit on the edge of so that my back is still straight.  And then I have a balance disc, or a sitting disc they’re called, and I can put that on my chair, and when I’m sitting on it, I have to continually kind of adjust my posture.  It scoots me forward on my sits bones, so it’s really hard to slouch while I’m sitting on it.  And then I have a yoga ball as well.  So I alternate back and forth between all of those different positions throughout the day, and I find that I feel best when I do that.  If I walk for too long, that actually can start tightening the hamstrings, and I feel a little bit too sore at the end of the day or just stiff, and it doesn’t feel good.  If I stand for too long, certainly I have that issue, and of course, if I sit for too long, I don’t feel good.  So for me, a mixture back and forth is ideal.  But if you do stand or even walk or some combination of both for the entire day, then something like what you described is probably helpful, and I can’t see how it would be harmful, so by all means, give that a shot.

Steve Wright:  So also has a follow-up question that I think is appropriate to address.  She also wanted to know if you had any thoughts or preferences about the shoes that you wear during the day and using an anti-fatigue mat for the standing desk.

Chris Kresser:  I do have an anti-fatigue mat, but unfortunately it’s now under the treadmill!  The treadmill is resting on it.  The reality is, along with what I just said, I stand comparatively little to walking.  I probably walk most, then I sit on the yoga ball and the chair and the sitting disc a distant second, and then third would probably be standing.  And that’s in part because the way my desk is set up now, the treadmill is under the desk.  So if I’m standing, I’m standing on the treadmill, which isn’t actually ideal from a biomechanical perspective, the way that it’s set up, and then the anti-fatigue mat is under the treadmill, so I’m not standing on that.  In terms of footwear, I’m barefoot.  If I’m in my home office, I’m barefoot whether on the treadmill or sitting or whatever.  Occasionally I’ll be wearing very thin-soled… I have some Patagonia shoes that are really kind of more barefoot than any other barefoot shoes I’ve tried except for Vibrams and maybe a few others.  And so sometimes I’ll wear those if I’ve been outside and I’ve just come back or something like that.  But I think minimalist footwear is always a good idea for this kind of thing.

Steve Wright:  All right, awesome.  I think this next question is very appropriate for this podcast.  Eden wants to know, “Where did humans traditionally get magnesium in their diet?”

Chris Kresser:  Yeah, this is a question that often comes up, and I’m not entirely sure.  One thing that I’ve heard and read about quite a few times and I’ve been searching around in the scientific literature for something to corroborate this, but I’ve found general references to nutrient depletion in the soil that would include magnesium, but I haven’t found any specific comparisons between soil from preindustrial times or maybe a place that hasn’t been developed with monocropping and industrialized agriculture in a more rural place, but there’s this idea that the diversity and the quality of nutrients in soil has changed quite a bit since the industrialization of agriculture.  And it’s not just an idea.  I mean, there is data to support this.  So there was probably more magnesium in nuts and seeds and even some vegetables and fruits and starches like plantains than there is now, so there was just more magnesium in the diet due to better soil quality.

But in terms of the diet now and historically, nuts and seeds have been one of the highest sources of magnesium.  One of the issues there, though, is traditional cultures almost always prepared nuts and seeds by soaking them and then drying them.  And we know that nuts and seeds have phytate, phytic acid, which inhibits the absorption of magnesium and that these traditional preparation methods, like soaking and drying, break down the phytate so that more of the nutrients and minerals in the food can be absorbed.  So it’s possible that they got most of their magnesium from nuts and seeds.  Today in the sort of modern diet, pumpkin seeds and Brazil nuts are relatively high in magnesium.  Like 6-8 Brazil nuts have about 107 mg of magnesium.  A half ounce of pumpkin seeds has about 75 mg.  Buckwheat is actually a seed.  It’s not related to wheat at all, in spite of its name, and a cup of buckwheat flour has about 300 mg of magnesium.  And actually plantains are a good source of magnesium.  One medium plantain has about 65 mg of magnesium.

But I generally would recommend that people get 400 to 500 mg of magnesium, if not more if they’re dealing with constipation or muscle pain or some other symptoms, and that, in my experience, it’s just really difficult to get from the diet, so that’s one of the reasons I recommend it as one of the few nutrients that most people benefit from supplementing with.

Steve Wright:  Do you do anything special in your daily life to ensure that you get magnesium, like supplement?  Or do you do it all through food?

Chris Kresser:  I take a magnesium supplement.  Magnesium and fermented cod liver oil are the only two supplements that I take.  I have tried to get magnesium from food, and I notice a difference when I’m not supplementing with magnesium, so as I said, along with fermented cod liver oil, it’s the only one I take on a regular basis.

Steve Wright:  Awesome.  All right, let’s move on to the next question.  This question comes from Christina, and Christina has a little bit of a paragraph here, so bear with me.  She has a soon-to-be 1-year-old son, and she has yet to have her first period.  She’s still nursing him two to three times a day plus pumping once at night.  She works part time, so the pumping at night is for during the next day.  Her pediatrician said that she should ditch the pump when he turns 1, despite knowing all the benefits of breastfeeding.  “I have to say that I’m ‘pumped’ to get rid of it.  Bad pun, but anyway, I’m wondering how normal this is.  He’s my first son, and I have a history of irregular periods.  Do some people have amenorrhea until they completely wean their child?  Is there any risk involved with not having a period?  My biggest concern is that my husband and I would like to start trying again, and knowing that I am getting my period would help me a lot.  Would you recommend acupuncture treatments to help me get things started again?  Thanks for all your help.”

Chris Kresser:  OK, so I just want to take a step back and throw in my plug for complementary nursing until at least 22 months.  I know she’s pumped to stop pumping, and I completely understand that.  I’ve worked with a lot of women who have had to pump a lot, and I know it can be difficult, but there’s a considerable amount of research that suggests that along with exclusive breastfeeding to 6 months that there’s a real and measurable benefit to continuing to do supplemental breastfeeding up to 22 months.  And the recommendation is to just do it on demand, meaning you offer it when baby wants it.  Of course, that’s not necessarily practical in this situation, given the work schedule and the pumping and things like that.  But I would encourage you to at least consider biting the bullet and continuing for up to 22 months or as close to that as you can get because I think the research suggests that there’s some significant benefit there.  The benefit seems to stop from a health perspective at around 22 months.  I mean, of course, that’s an estimate.  It’s going to vary from baby to baby, but that’s a general guideline.  The decision to nurse beyond 22 months really depends more on parenting philosophy and questions of attachment and development and things like that.  It’s not really related to nutrition in most cases.

In terms of the amenorrhea, it’s not unusual to be amenorrheic at one year if you’re nursing.  And different women have a different ‘normal’ here.  Some women start menstruating really relatively quickly even if they’re still nursing.  Other women take quite a while to get back to menstruation when they’re nursing.  And it doesn’t necessarily indicate any kind of pathology or problem; different women just have a different rhythm and pattern there.  In some cases, it can indicate a problem, a hormone imbalance, something that’s not clicking back into place after the birth, but I wouldn’t suspect that at 1 year, especially given the history of irregular menstrual cycles before.  And someone who has a history of irregular menstrual cycles is more likely, in my experience, to be a little bit slower getting back into their normal rhythm since their rhythm wasn’t really normal in the first place.  It sounds to me like there isn’t anything to be concerned about, but of course, that’s something you should also double-check with your OB/GYN or midwife or whoever’s care you’re under.

Steve Wright:  All right, so let’s move on to the next question.  “What are your thoughts on supplemental support with PharmaGABA and/or L-theanine during pregnancy?  What about certain adaptogens, like ashwagandha, during pregnancy?  This would be in regards to anxiety during pregnancy.  Thanks for your consideration.  Ben”

Chris Kresser:  GABA is the major inhibitory neurotransmitter, for anyone who doesn’t know what GABA is.  It’s kind of like the off-switch in the brain and elsewhere.  It leads to feelings of calmness and relaxation, and so the idea, of course, is supplementing with GABA would reduce anxiety.  But GABA is a very large molecule, and it shouldn’t actually cross the blood-brain barrier, is my understanding.  And so if you take GABA and you have a response, some practitioners kind of actually use that as a way of diagnosing leaky brain.  We’ve talked a lot about leaky gut, I’ve even written a bit about leaky skin, but the blood-brain barrier is another barrier system in the body that’s designed to keep certain things out and let certain things in, and large molecules are not supposed to pass through the blood-brain barrier.  There’s one school of thought that says that supplementing with GABA shouldn’t work, and if it does work, it’s actually indicative of a leaky blood-brain barrier and that’s what should be investigated and treated.

But as far as this question goes, supplements during pregnancy are always a tricky thing because we don’t have a lot of data on the safety of supplements during pregnancy, and we never will because those studies are unethical to do.  Imagine a trial where you take two groups of pregnant women and you give one group a supplement and give the other a placebo and then you watch what happens to them and their babies.  I mean, obviously no one is going to sign up for that study and they shouldn’t.  It’s completely unethical.  So we’re left kind of wondering a lot about the effect of various supplements, and the only way to really know is to, in some cases, look at the history of safe use of those supplements by herbalists and other types of health care practitioners throughout history.  You can consider the mechanism of how the substance works and whether it’s likely to shift anything around in pregnancy, although it’s pretty sketchy to do it that way because we just don’t know.  I mean, there are so many profound changes in pregnancy that it’s really difficult to predict how something might impact the developing baby or the mother.

So my general philosophy on supplementation during pregnancy is to be extra cautious, to do as much as possible with lifestyle-based interventions and diet, and when using supplements, to use only the ones that have the longest record of safe use and that are the least likely to cause any harm or difficulty.  For anxiety during pregnancy, I will tend to recommend acupuncture.  It seems to really take the edge off for a lot of women.  The only side effects are typically feeling better, for the most part, and it’s pretty affordable these days if you find a community acupuncture clinic.  Mindfulness-based stress reduction, which we’ve talked about numerous times on the show, and the Rest Assured program are two ways of inducing the parasympathetic nervous system, and mindfulness-based stress reduction, particularly, is clinically proven to reduce anxiety in several different studies, and that you can search online for a class nearby or you can even download some free audio programs.  The body scan is one way of doing MBSR, mindfulness-based stress reduction.  You can download some of those for free from the Internet to learn how to do it.

Then there are some botanicals, like skullcap — Chinese skullcap, not American skullcap.  There are two different varieties.  It’s really important.  Chinese skullcap is generally considered by most herbalists to be safe during pregnancy, particularly when taken as a tea.  Lemon balm and chamomile are two other botanicals that are generally considered to be safe.  And if you use one of the over-the-counter teas that have them in it or you combine those together, they’re generally, again, considered to be safe.  Now, if you search for some of these on the Internet, you might see some mixed views, and that’s in part because of what I just said before.  We don’t have randomized clinical trials that give us this type of information, and different people have a different take, but the vast majority of even mainstream sources consider chamomile and Chinese skullcap and lemon balm to be safe.  American skullcap is not considered to be safe.

5-HTP, which is an intermediate between tryptophan and serotonin and is often used for depression and anxiety in non-pregnant people, is questionable.  There are mixed opinions, again, about that.  And I would be hesitant myself to prescribe it during pregnancy because we just don’t know.  On the other hand, a lot of doctors do prescribe SSRIs, prescription antidepressants that, I think, have probably an even greater impact on serotonin metabolism than taking 5-HTP, and a lot of women take SSRIs during pregnancy.  I’m not arguing for that, and two wrongs don’t make a right, of course, but I guess it depends on the extent of the anxiety and depression because that can be harmful for the baby as well, especially if it leads to harmful behavior in the mother.

So if you’re going to explore any of those more, 5-HTP or anything like that, absolutely do it in conversation with your healthcare provider or under the supervision of whomever you’re working with.  Otherwise, the lifestyle interventions, like acupuncture and mindfulness-based stress reduction, spending time outdoors, making sure to get plenty of sleep if possible — I know that’s sometimes challenging when you’re pregnant, especially in the later stages — and then considering using some of those teas, when you add all of those kind of smaller interventions up, they can actually equal a larger intervention.

Steve Wright:  Awesome.  Well we’ve covered a lot of different topics today from science on why we should be eating what we’re eating and pregnancy to standing desks to all kinds of things.

Chris Kresser:  Yeah, and it was a lot more enjoyable than being in the closet.

Steve Wright:  You just like the window!

Chris Kresser:  Hopefully the sound is good, and next time it’ll be even better because I’ll have my fancy new sound-dampening equipment, which I’m excited about.

Steve Wright:  Awesome.  Well, as always, Chris, thanks for all the wealth of information.

Chris Kresser:  Thank you, Steve.  Pleasure, and see you all next time.

Steve Wright:  Yeah.  Thanks, everyone, for listening today.  If you would, please keep sending us your questions to ChrisKresser.com.  I swear I still have them, and we’re plowing through the list as we go.  When you get to ChrisKresser.com, use the podcast submission link to send them over to me.  And if you enjoyed listening to the show, please head over to iTunes and leave us a review.  Thanks.  We’ll talk to you next time.

Tagged as: anxiety, cholesterol, ldl, magnesium, pregnancy

Chris Kresser I hate spam too. Your email is safe with me.

Follow Chris Online:

Personal Paleo Code icon

Discover your own ideal diet & end confusion about what to eat forever.

Learn More healthy Baby Code icon

Boost fertility naturally & promote lifelong health for you & your baby.

Learn More Personal Paleo Launchpad icon

Personalized online portal with easy-to-use tools, expert advice, and the support of a passionate, intelligent community.

Learn More Paleologix icon

Break through the energy swings, digestive upset, and obstacles of adopting a Paleo diet.

Learn More

View the original article here

The Roundup

RoundupHere is The Roundup, Edition 4, bringing you the best from around the web from the past two weeks! This week, I’m focusing on articles that address diabetes, obesity, and related metabolic disorders.

In 2011, I wrote an article explaining the many factors affecting the development of diabetes and obesity, and how many of the proposed mechanisms could conceivably contribute to the development of the disease. As obesity and diabetes research advances, however, the interconnection between these proposed mechanisms is becoming more clear, yet no primary treatment protocol has been established. And as I’ve mentioned before, I doubt one single treatment will ever be devised; after all, we’re not robots!

Recently, two studies were published suggesting alternative treatments that could help obese and diabetic patients lose weight and improve metabolic function. One study found that intermittent fasting (IF) may be a possible treatment protocol to help with weight loss and recover metabolic function, as IF has been found to limit inflammation, boost pancreatic function, and decrease levels of sugars and lipids in circulation. Another study demonstrated that intestinal parasites may be a potential diabetes and obesity treatment, as certain parasites may be able to mitigate inflammation, improve glucose tolerance, and prevent excess weight gain. Perhaps in the future, the recommendation to “eat less and exercise more” will be a distant memory, and these novel treatments will be considered the norm!

Fossil record shows early hominids hunted animals and ate their brains as early as 2 million years ago.A psychiatrist says that ADHD might actually be a misdiagnosed sleep disorderA study shows that increased efforts are needed to regulate the supplement industry.A small clinical trial suggests that fecal transplantation may help reduce or eliminate symptoms of ulcerative colitis in most children and young adults.Collaboration between veterinary and human medicine offers a cross-species perspective on a range of human health problems.Research by the NIH finds that women with sufficient amounts of vitamin D have a 32% lower risk of developing uterine fibroids.Mercola.com: My interview with Dr. Mercola on one of the most important tests for heart disease you can get.Stumptuous.com: Krista Scott-Dixon explains hormones, homeostasis, and why you (probably) need carbs.Ancestralize Me: A young woman shares her experience with using ancestral nutrition to manage her autoimmune condition.Rodale: Carageenan hides out in a lot of your favorite foods, causing inflammation, gut irritation, and potentially even cancer.Chris Kresser I hate spam too. Your email is safe with me.

Follow Chris Online:

Personal Paleo Code icon

Discover your own ideal diet & end confusion about what to eat forever.

Learn More healthy Baby Code icon

Boost fertility naturally & promote lifelong health for you & your baby.

Learn More Personal Paleo Launchpad icon

Personalized online portal with easy-to-use tools, expert advice, and the support of a passionate, intelligent community.

Learn More Paleologix icon

Break through the energy swings, digestive upset, and obstacles of adopting a Paleo diet.

Learn More

View the original article here